Platelet antibody of blood donors in Suzhou
Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 8
Abstract
Objective To study the incidence and specificity of platelet antibody in blood donors in Suzhou, analyze the distribution characteristics of platelet antibody in blood donors in this area, and explore the significance of platelet antibody detection in blood donors to reduce the adverse reactions toplatelet transfusion in clinical. Methods Platelet antibody detection was performed in 2178 blood donors in this area by solid-phase immunosorbent assay. The antibody specificity of the positive samples was analyzed by commercial kit, and the anti-CD36 antibody positive samples were further identified by flow cytometry and gene sequencing. Results Twelve positive samples were detected by platelet antibody screening, with a positive rate of 0.55%(12/2 178), including 5 males (0.33%, 5/2 178)and 7 females(1.06%, 7/2 178). Among the positive samples, anti-HLA-Ⅰ antibody was identified in 2 cases, anti-CD36 antibody in 1 case, and the antibody specificity was not identified in the other 9 cases. In one case, the positive rate of anti-HLA-Ⅰ antibody PRA was 31.31%(31/ 99), which was mainly specific to anti-B15, anti-B35 and anti-B40. The positive rate of anti-HLA-Ⅰ antibody PRA in the other case was 45.45%(45/ 99), which was mainly specific to anti-A2, anti-A11, anti-A24, anti-A29, anti-A33, anti-A66, anti-B15 and anti-B35. The blood donor with anti-CD36 antibody was type I CD36 deficiency, and 329_330delAC mutation occurred in exon 5. Conclusion Through antibody screening and specificity identification, the positive rate of platelet antibody in females was significantly higher than that in males(P<0.05). In addition to the common anti-HLA-I antibodies, anti-CD36 antibody was also detected in type I CD36 deficient blood donor. Therefore, the detection of platelet antibodies in blood donors is of certain clinical significance to reduce the adverse reactions to blood transfusion caused by antibodies in platelet products.
Authors and Affiliations
Li DONG, Ming FANG, Yujue WANG, Honghong HE, Hongmei WANG, Yezhou CHEN, Feiran Wu, Shengbao DUAN, Longhai TANG
Keywords
Related Articles
- EP ID EP738311
- DOI 10.13303/j.cjbt.issn.1004-549x.2022.08.004
- Views 68
- Downloads 0
Application of therapeutic hemapheresis and the adverse reactions
Objective To discuss the application of therapeutic hemapheresis in clinical therapy and to observe the adverse reactions. Methods 126 times of therapeutic hemapheresis were performed in 121 patients by Nangel blood cell...
Application of blood/fluid warmer during plateletpheresis in winter and its nursing
Objective To study the safety, effectiveness and nursing of blood/fluid warmer during the process of plateletpheresis in winter. Methods The blood re-transfusion speed during plateletpheresis in winter and the time of bl...
Influencing factors of clinical efficacy of autologous platelet-rich plasma in the treatment of androgenetic alopecia
Objective To analyze the influencing factors of clinical efficacy of autologous platelet-rich plasma in the treatment of androgenetic alopecia. Methods From January, 2019 to December, 2021, 151 outpatients with androgene...
Assessment of residual risk of hepatitis C virus transmission by blood transfusion in Taiyuan
Objective To analyze the epidemic of hepatitis C virus (HCV) in voluntary blood donors , and to assess the residual risk of HCV transmission by blood transfusion in Taiyuan. Methods The HCV screening results of voluntary...
Genetic background of RhD negative blood donors
Objective To analyze the genetic background of RhD-negative blood donors by detecting RHD and RHCE genes of those donors. Methods From March 2021 to May 2022, the blood samples of RhD-negative blood donors, who had been...